Home Other Building Blocks 39219-28-8
39219-28-8,MFCD00867247
Catalog No.:AA00I7NZ

39219-28-8 | Estra-1,3,5(10)-triene, 17-methoxy-3-propoxy-, (17b)-

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
95%
in stock  
$61.00   $43.00
- +
5mg
≥95%
in stock  
$105.00   $73.00
- +
10mg
≥95%
in stock  
$198.00   $138.00
- +
250mg
98%
in stock  
$306.00   $214.00
- +
1g
98%
in stock  
$674.00   $472.00
- +
5g
98%
in stock  
$2,082.00   $1,458.00
- +
10g
98%
in stock  
$3,125.00   $2,188.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA00I7NZ
Chemical Name:
Estra-1,3,5(10)-triene, 17-methoxy-3-propoxy-, (17b)-
CAS Number:
39219-28-8
Molecular Formula:
C22H32O2
Molecular Weight:
328.4883
MDL Number:
MFCD00867247
SMILES:
CCCOc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2OC)C
Properties
Properties
 
BP:
436.799°C at 760 mmHg  
Form:
Solid  
MP:
64-660C  
Storage:
Keep in dry area;2-8℃;  

Computed Properties
 
Complexity:
436  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
5  
Heavy Atom Count:
24  
Hydrogen Bond Acceptor Count:
2  
Rotatable Bond Count:
4  
XLogP3:
4.5  

Literature

Title: Comparative uterine effects on ovariectomized rats after repeated treatment with different vaginal estrogen formulations.

Journal: Maturitas 20120801

Title: Effect of one-month treatment with vaginal promestriene on serum estrone sulfate levels in cancer patients: a pilot study.

Journal: Maturitas 20120501

Title: Urogenital disorders associated with oestrogen deficiency: the role of promestriene as topical oestrogen therapy.

Journal: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20100901

Title: [Safety of promestriene capsule used in postmenopausal atrophic vaginitis].

Journal: Zhonghua fu chan ke za zhi 20090801

Title: Estrogen therapy influence on periurethral vessels in postmenopausal incontinent women using Dopplervelocimetry analysis.

Journal: Maturitas 20081120

Title: Atypical squamous cells and low squamous intraepithelial lesions in postmenopausal women: implications for management.

Journal: European journal of obstetrics, gynecology, and reproductive biology 20081001

Title: Presurgical promestriene therapy in postmenopausal women with stress urinary incontinence.

Journal: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20070101

Title: Isabel Santos, et al. Urogenital Disorders Associated With Oestrogen Deficiency: The Role of Promestriene as Topical Oestrogen Therapy. Gynecol Endocrinol. 2010 Sep;26(9):644-51.

Title: Lino Del Pup, et al. Promestriene, a Specific Topic Estrogen. Review of 40 Years of Vaginal Atrophy Treatment: Is It Safe Even in Cancer Patients. Anticancer Drugs. 2013 Nov;24(10):989-98.

Title: AJO Almodovar, et al. Abstract P5-05-07: Promestriene effects on estrogen-sensitive breast cancer cell proliferation in vitro. Cancer Res 2013;73(24 Suppl): Abstract nr P5-05-07.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:39219-28-8 Molecular Formula|39219-28-8 MDL|39219-28-8 SMILES|39219-28-8 Estra-1,3,5(10)-triene, 17-methoxy-3-propoxy-, (17b)-